The rise of Viagra and its effect on the drug landscape presents a intricate question for shareholders. While the initial sales figures were impressive, the patent has lapsed, leading to a wave of generic alternatives https://lawsontely340260.blogthisbiz.com/49110214/the-blue-pill-and-pharma-a-dangerous-investment